| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 2.49e-05 | 10 | 126 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | MXRA5 APCS LAMA4 LAMC1 LAMC2 COL6A5 FREM3 ITIH5 BMP1 TGM2 MFGE8 SMC3 | 8.83e-05 | 530 | 126 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RGPD2 RANBP2 PDCD6 ATG7 MYO9B LAMC2 ADGRV1 SRCAP RAB3C TG TGM2 PKHD1 TENM1 PAM MAEL GALNT4 | 1.58e-04 | 934 | 126 | 16 | GO:0048471 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.63e-04 | 18 | 126 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.26e-04 | 20 | 126 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | chromosomal region | 2.38e-04 | 421 | 126 | 10 | GO:0098687 | |
| GeneOntologyCellularComponent | pore complex | 5.02e-04 | 26 | 126 | 3 | GO:0046930 | |
| GeneOntologyCellularComponent | extracellular matrix | MXRA5 APCS LAMA4 LAMC1 LAMC2 COL6A5 FREM3 ITIH5 BMP1 TGM2 MFGE8 SMC3 | 6.18e-04 | 656 | 126 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | MXRA5 APCS LAMA4 LAMC1 LAMC2 COL6A5 FREM3 ITIH5 BMP1 TGM2 MFGE8 SMC3 | 6.34e-04 | 658 | 126 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | mitochondrial permeability transition pore complex | 7.42e-04 | 7 | 126 | 2 | GO:0005757 | |
| GeneOntologyCellularComponent | basement membrane | 8.68e-04 | 122 | 126 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 9.86e-04 | 8 | 126 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | synaptic cleft | 1.02e-03 | 33 | 126 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 1.27e-03 | 78 | 126 | 4 | GO:0001917 | |
| GeneOntologyCellularComponent | secretory vesicle | ATG7 CLEC5A SLC6A17 DCST1 F8 RAB3C MFGE8 SCCPDH AP2A2 BRCA2 PRCP SERPINB3 CLTC PAM GKN1 VDAC1 VDAC3 | 1.32e-03 | 1246 | 126 | 17 | GO:0099503 |
| GeneOntologyCellularComponent | laminin complex | 1.57e-03 | 10 | 126 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | inclusion body | 2.16e-03 | 90 | 126 | 4 | GO:0016234 | |
| Domain | YIPPEE | 9.51e-09 | 5 | 125 | 4 | PS51792 | |
| Domain | Yippee/Mis18/Cereblon | 1.31e-07 | 8 | 125 | 4 | IPR004910 | |
| Domain | Yippee-Mis18 | 1.31e-07 | 8 | 125 | 4 | PF03226 | |
| Domain | EGF | 2.92e-05 | 235 | 125 | 9 | SM00181 | |
| Domain | EGF-like_dom | 4.59e-05 | 249 | 125 | 9 | IPR000742 | |
| Domain | EGF_1 | 5.52e-05 | 255 | 125 | 9 | PS00022 | |
| Domain | EGF-like_CS | 6.61e-05 | 261 | 125 | 9 | IPR013032 | |
| Domain | NHL | 7.97e-05 | 13 | 125 | 3 | PS51125 | |
| Domain | EUKARYOTIC_PORIN | 1.33e-04 | 3 | 125 | 2 | PS00558 | |
| Domain | BMP_1/tolloid-like | 1.33e-04 | 3 | 125 | 2 | IPR015446 | |
| Domain | Tox-GHH_dom | 2.64e-04 | 4 | 125 | 2 | IPR028916 | |
| Domain | Tox-GHH | 2.64e-04 | 4 | 125 | 2 | PF15636 | |
| Domain | Ten_N | 2.64e-04 | 4 | 125 | 2 | IPR009471 | |
| Domain | Ten_N | 2.64e-04 | 4 | 125 | 2 | PF06484 | |
| Domain | TENEURIN_N | 2.64e-04 | 4 | 125 | 2 | PS51361 | |
| Domain | CUB | 3.21e-04 | 49 | 125 | 4 | PF00431 | |
| Domain | CUB | 3.47e-04 | 50 | 125 | 4 | SM00042 | |
| Domain | FA58C | 3.56e-04 | 21 | 125 | 3 | SM00231 | |
| Domain | FA58C_3 | 3.56e-04 | 21 | 125 | 3 | PS50022 | |
| Domain | FA58C_1 | 3.56e-04 | 21 | 125 | 3 | PS01285 | |
| Domain | FA58C_2 | 3.56e-04 | 21 | 125 | 3 | PS01286 | |
| Domain | - | 4.04e-04 | 52 | 125 | 4 | 2.60.120.290 | |
| Domain | EGF_2 | 4.16e-04 | 265 | 125 | 8 | PS01186 | |
| Domain | CUB | 4.34e-04 | 53 | 125 | 4 | PS01180 | |
| Domain | Porin_dom | 4.39e-04 | 5 | 125 | 2 | IPR023614 | |
| Domain | - | 4.39e-04 | 5 | 125 | 2 | 2.40.160.10 | |
| Domain | Porin_Euk/Tom40 | 4.39e-04 | 5 | 125 | 2 | IPR027246 | |
| Domain | Porin_3 | 4.39e-04 | 5 | 125 | 2 | PF01459 | |
| Domain | YD | 4.39e-04 | 5 | 125 | 2 | IPR006530 | |
| Domain | Porin_Euk | 4.39e-04 | 5 | 125 | 2 | IPR001925 | |
| Domain | F5_F8_type_C | 5.34e-04 | 24 | 125 | 3 | PF00754 | |
| Domain | FA58C | 5.34e-04 | 24 | 125 | 3 | IPR000421 | |
| Domain | CUB_dom | 5.74e-04 | 57 | 125 | 4 | IPR000859 | |
| Domain | LCCL | 6.55e-04 | 6 | 125 | 2 | PS50820 | |
| Domain | SMC_hinge | 6.55e-04 | 6 | 125 | 2 | SM00968 | |
| Domain | SMC_hinge | 6.55e-04 | 6 | 125 | 2 | PF06470 | |
| Domain | Peptidase_M12A | 6.55e-04 | 6 | 125 | 2 | IPR001506 | |
| Domain | LCCL | 6.55e-04 | 6 | 125 | 2 | SM00603 | |
| Domain | LCCL | 6.55e-04 | 6 | 125 | 2 | PF03815 | |
| Domain | Astacin | 6.55e-04 | 6 | 125 | 2 | PF01400 | |
| Domain | LCCL | 6.55e-04 | 6 | 125 | 2 | IPR004043 | |
| Domain | - | 6.55e-04 | 6 | 125 | 2 | 2.170.130.20 | |
| Domain | SMC_hinge | 6.55e-04 | 6 | 125 | 2 | IPR010935 | |
| Domain | EGF_LAM_2 | 1.04e-03 | 30 | 125 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.04e-03 | 30 | 125 | 3 | PS01248 | |
| Domain | Calx_beta | 1.21e-03 | 8 | 125 | 2 | SM00237 | |
| Domain | LAMININ_IVA | 1.21e-03 | 8 | 125 | 2 | PS51115 | |
| Domain | Laminin_B | 1.21e-03 | 8 | 125 | 2 | PF00052 | |
| Domain | LamB | 1.21e-03 | 8 | 125 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.21e-03 | 8 | 125 | 2 | IPR000034 | |
| Domain | - | 1.46e-03 | 73 | 125 | 4 | 2.60.120.260 | |
| Domain | Calx_beta | 1.55e-03 | 9 | 125 | 2 | IPR003644 | |
| Domain | Calx-beta | 1.55e-03 | 9 | 125 | 2 | PF03160 | |
| Domain | EGF_Lam | 1.64e-03 | 35 | 125 | 3 | SM00180 | |
| Domain | Laminin_EGF | 1.64e-03 | 35 | 125 | 3 | PF00053 | |
| Domain | Laminin_EGF | 2.08e-03 | 38 | 125 | 3 | IPR002049 | |
| Domain | - | 2.24e-03 | 39 | 125 | 3 | 2.120.10.30 | |
| Domain | Ran_BP1 | 2.81e-03 | 12 | 125 | 2 | PF00638 | |
| Domain | RANBD1 | 2.81e-03 | 12 | 125 | 2 | PS50196 | |
| Domain | RanBD | 3.30e-03 | 13 | 125 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 3.30e-03 | 13 | 125 | 2 | IPR000156 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.60e-03 | 46 | 125 | 3 | IPR011042 | |
| Domain | Galactose-bd-like | 3.67e-03 | 94 | 125 | 4 | IPR008979 | |
| Domain | - | 3.81e-03 | 95 | 125 | 4 | 2.60.120.200 | |
| Domain | P-loop_NTPase | SPG7 MYO9B MYO10 KIF21A CHD4 SRCAP RAB3C NLRC4 KIF7 SMC3 GUK1 TAP2 CHST3 | 4.48e-03 | 848 | 125 | 13 | IPR027417 |
| Domain | EGF_3 | 5.04e-03 | 235 | 125 | 6 | PS50026 | |
| Pubmed | 8.73e-10 | 5 | 128 | 4 | 15556292 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | RGPD2 RANBP2 NUP98 TGM2 SCCPDH SMC3 HADHA ALDH1A1 GOT1 VDAC3 | 1.28e-08 | 226 | 128 | 10 | 37839992 |
| Pubmed | 3.61e-08 | 10 | 128 | 4 | 20580816 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MXRA5 PDCD6 APCS LAMC1 ADGRV1 SLC44A4 TGM2 MFGE8 PRCP SERPINB3 BEND7 CLTC PKHD1 ALDH1A1 CPVL GOT1 VDAC1 VDAC3 | 3.82e-08 | 1016 | 128 | 18 | 19056867 |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.22e-07 | 13 | 128 | 4 | 31427429 | |
| Pubmed | RGPD2 RANBP2 PCDHGB5 NELFCD SMCHD1 KIF21A NUP98 CHD4 TEX14 SRCAP RAB3C SCCPDH AP2A2 CLTC PKHD1 TENM1 HADHA ALDH1A1 VDAC3 | 1.44e-06 | 1442 | 128 | 19 | 35575683 | |
| Pubmed | 1.69e-06 | 7 | 128 | 3 | 7921537 | ||
| Pubmed | 3.01e-06 | 167 | 128 | 7 | 22159717 | ||
| Pubmed | PCDHGB5 LAMA4 LAMC1 MFGE8 CLTC PAM ALDH1A1 CRISPLD1 GALNT4 GOT1 | 3.56e-06 | 417 | 128 | 10 | 19199708 | |
| Pubmed | 5.73e-06 | 10 | 128 | 3 | 11784026 | ||
| Pubmed | 5.73e-06 | 10 | 128 | 3 | 9034910 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | RANBP2 SMCHD1 CHD4 BRCA2 SERPINB3 SERPINB4 CLTC MED23 ZNF281 | 7.46e-06 | 357 | 128 | 9 | 37059091 |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 7.86e-06 | 11 | 128 | 3 | 23472759 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 7.86e-06 | 11 | 128 | 3 | 21524702 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | FAT4 PDCD6 APCS LAMC1 SI SLC44A4 TGM2 PRCP CLTC PAM ALDH1A1 CPVL CRISPLD1 GOT1 VDAC1 | 9.83e-06 | 1070 | 128 | 15 | 23533145 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 MYO9B POLD1 SMCHD1 KIF21A CHD4 SRCAP TGM2 NSUN5 AP2A2 SMC3 SERPINB3 SERPINB4 EIF2B3 CLTC HADHA ZNF281 | 1.01e-05 | 1353 | 128 | 17 | 29467282 |
| Pubmed | 1.05e-05 | 12 | 128 | 3 | 9396756 | ||
| Pubmed | 1.05e-05 | 202 | 128 | 7 | 24639526 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 1.13e-05 | 135 | 128 | 6 | 31077711 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.13e-05 | 135 | 128 | 6 | 28675934 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15203214 | ||
| Pubmed | Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure. | 1.34e-05 | 2 | 128 | 2 | 23354406 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 11907043 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 20069563 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 28923241 | ||
| Pubmed | Characterization of novel squamous cell carcinoma antigen-related molecules in mice. | 1.34e-05 | 2 | 128 | 2 | 15504361 | |
| Pubmed | Mouse chondroitin 6-sulfotransferase: molecular cloning, characterization and chromosomal mapping. | 1.34e-05 | 2 | 128 | 2 | 9597547 | |
| Pubmed | SCCA2-like serpins mediate genetic predisposition to skin tumors. | 1.34e-05 | 2 | 128 | 2 | 12702576 | |
| Pubmed | Lysoptosis is an evolutionarily conserved cell death pathway moderated by intracellular serpins. | 1.34e-05 | 2 | 128 | 2 | 35022507 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 27534968 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 25111616 | ||
| Pubmed | Squamous cell carcinoma antigen production in nasal inverted papilloma. | 1.34e-05 | 2 | 128 | 2 | 23168150 | |
| Pubmed | Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. | 1.34e-05 | 2 | 128 | 2 | 14970861 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 10653592 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 29112685 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 10956412 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 35874657 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22406480 | ||
| Pubmed | Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy. | 1.34e-05 | 2 | 128 | 2 | 27668655 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 24913494 | ||
| Pubmed | Ankyrin-G regulates inactivation gating of the neuronal sodium channel, Nav1.6. | 1.34e-05 | 2 | 128 | 2 | 16775201 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 20434446 | ||
| Pubmed | HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. | 1.34e-05 | 2 | 128 | 2 | 21423673 | |
| Pubmed | Serpinb3 is overexpressed in the liver in presence of iron overload. | 1.34e-05 | 2 | 128 | 2 | 28935635 | |
| Pubmed | VDAC1 serves as a mitochondrial binding site for hexokinase in oxidative muscles. | 1.34e-05 | 2 | 128 | 2 | 17207767 | |
| Pubmed | Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. | 1.34e-05 | 2 | 128 | 2 | 21403642 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 3211159 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 11267667 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 29491058 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 16951154 | ||
| Pubmed | The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. | 1.34e-05 | 2 | 128 | 2 | 11863458 | |
| Pubmed | IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. | 1.34e-05 | 2 | 128 | 2 | 22808225 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 10525161 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 25874799 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 20428762 | ||
| Pubmed | 1.44e-05 | 40 | 128 | 4 | 27068110 | ||
| Pubmed | 1.57e-05 | 215 | 128 | 7 | 36808153 | ||
| Pubmed | RANBP2 SPG7 PDCD6 POLD1 KIF7 SACM1L NSUN5 BRCA2 CDK5RAP1 USP54 VDAC3 | 1.59e-05 | 606 | 128 | 11 | 36538041 | |
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 1.71e-05 | 302 | 128 | 8 | 30561431 | |
| Pubmed | 1.72e-05 | 14 | 128 | 3 | 36347239 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.76e-05 | 146 | 128 | 6 | 23892456 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RANBP2 BPIFB3 NELFCD POLD1 NUP98 SMC3 KMT5B SERPINB3 SERPINB4 EIF2B3 CLTC OTUD4 HADHA CPVL VDAC1 VDAC3 | 2.08e-05 | 1284 | 128 | 16 | 17353931 |
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 2.14e-05 | 15 | 128 | 3 | 12921739 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 2.14e-05 | 15 | 128 | 3 | 15895400 | |
| Pubmed | RANBP2 PDCD6 POLD1 LAMC1 CHD4 UBN2 SACM1L SCCPDH AP2A2 EIF2B3 CLTC HADHA SLC30A9 CPVL TAP2 VDAC1 VDAC3 | 2.24e-05 | 1440 | 128 | 17 | 30833792 | |
| Pubmed | 2.46e-05 | 415 | 128 | 9 | 16385451 | ||
| Pubmed | 2.59e-05 | 320 | 128 | 8 | 28685749 | ||
| Pubmed | 2.63e-05 | 16 | 128 | 3 | 17601529 | ||
| Pubmed | 3.26e-05 | 49 | 128 | 4 | 21362503 | ||
| Pubmed | 3.82e-05 | 18 | 128 | 3 | 14730302 | ||
| Pubmed | 3.82e-05 | 18 | 128 | 3 | 11311202 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | OMA1 ZNF765 RANBP2 LAMC1 CHD4 SACM1L SCCPDH AP2A2 ZNF283 CLTC SLC30A9 MED23 ZNF281 TAP2 THAP12 | 3.82e-05 | 1203 | 128 | 15 | 29180619 |
| Pubmed | Centrosome-related genes, genetic variation, and risk of breast cancer. | 3.91e-05 | 102 | 128 | 5 | 20508983 | |
| Pubmed | A novel mouse mitochondrial voltage-dependent anion channel gene localizes to chromosome 8. | 4.02e-05 | 3 | 128 | 2 | 8812436 | |
| Pubmed | The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series. | 4.02e-05 | 3 | 128 | 2 | 11221880 | |
| Pubmed | Cardioprotection by N-acetylglucosamine linkage to cellular proteins. | 4.02e-05 | 3 | 128 | 2 | 18285568 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 18824173 | ||
| Pubmed | Revised fine mapping of the human voltage-dependent anion channel loci by radiation hybrid analysis. | 4.02e-05 | 3 | 128 | 2 | 10501981 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 11437399 | ||
| Pubmed | Novel pathogenic variants and multiple molecular diagnoses in neurodevelopmental disorders. | 4.02e-05 | 3 | 128 | 2 | 31238879 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 22451727 | ||
| Pubmed | Genetic analysis of the role of proteolysis in the activation of latent myostatin. | 4.02e-05 | 3 | 128 | 2 | 18286185 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 20432434 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 18697739 | ||
| Pubmed | Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC). | 4.02e-05 | 3 | 128 | 2 | 24635038 | |
| Pubmed | Heparin enhances serpin inhibition of the cysteine protease cathepsin L. | 4.02e-05 | 3 | 128 | 2 | 19959474 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 11807096 | ||
| Pubmed | Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells. | 4.02e-05 | 3 | 128 | 2 | 19070595 | |
| Pubmed | Perturbation of endoplasmic reticulum proteostasis triggers tissue injury in the thyroid gland. | 4.02e-05 | 3 | 128 | 2 | 37345654 | |
| Pubmed | Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. | 4.02e-05 | 3 | 128 | 2 | 9988277 | |
| Pubmed | A maxi-chloride channel in the inner membrane of mammalian mitochondria. | 4.02e-05 | 3 | 128 | 2 | 18805391 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 12404104 | ||
| Pubmed | Androgen pathway dysregulation in BRCA1-mutated breast tumors. | 4.02e-05 | 3 | 128 | 2 | 12779088 | |
| Pubmed | Multiple interactions of auxilin 1 with clathrin and the AP-2 adaptor complex. | 4.02e-05 | 3 | 128 | 2 | 11470803 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 9828132 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 19818997 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 7724531 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 24898082 | ||
| Pubmed | Unusual structural organization of the endocytic proteins AP180 and epsin 1. | 4.02e-05 | 3 | 128 | 2 | 11756460 | |
| Pubmed | A nonredundant role for mouse Serpinb3a in the induction of mucus production in asthma. | 4.02e-05 | 3 | 128 | 2 | 21126757 | |
| Interaction | TREX2 interactions | 1.72e-06 | 58 | 127 | 6 | int:TREX2 | |
| Interaction | CLEC11A interactions | 2.50e-06 | 96 | 127 | 7 | int:CLEC11A | |
| GeneFamily | Yippee like family | 1.96e-09 | 5 | 82 | 4 | 1130 | |
| GeneFamily | Laminin subunits | 1.92e-05 | 12 | 82 | 3 | 626 | |
| GeneFamily | Voltage dependent anion channels | 6.08e-05 | 3 | 82 | 2 | 306 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 3.01e-04 | 6 | 82 | 2 | 894 | |
| GeneFamily | Endogenous ligands|C1q and TNF related | 2.97e-03 | 18 | 82 | 2 | 1372 | |
| GeneFamily | Carboxypeptidases | 4.03e-03 | 21 | 82 | 2 | 1321 | |
| Coexpression | NABA_MATRISOME | MXRA5 CLEC5A LAMA4 LAMC1 C1QL4 LAMC2 COL6A5 FREM3 ITIH5 C1QL1 BMP1 TGM2 MFGE8 SERPINB3 SERPINB4 TLL2 GRIFIN CRISPLD1 | 2.34e-06 | 1026 | 127 | 18 | M5889 |
| Coexpression | NABA_MATRISOME | CLEC5A LAMA4 LAMC1 C1QL4 LAMC2 COL6A5 FREM3 ITIH5 C1QL1 BMP1 TGM2 MFGE8 SERPINB3 SERPINB4 TLL2 GRIFIN CRISPLD1 | 7.69e-06 | 1008 | 127 | 17 | MM17056 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.54e-09 | 199 | 128 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-08 | 171 | 128 | 8 | 5447b78148f7bccb727e2fc108589b2af02a5d31 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-08 | 172 | 128 | 8 | a7eee0a30d2fe20c865a07b9004c6a821a72c0c4 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-08 | 172 | 128 | 8 | 0a9fe2cd28203970295a1288078c66eadac1c9ed | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.16e-07 | 199 | 128 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.20e-07 | 200 | 128 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | droplet-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-07 | 169 | 128 | 7 | 53690d6f9712b54aa99a0408aae930d64ae478e5 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.84e-07 | 179 | 128 | 7 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 188 | 128 | 7 | 842982de2197770f999a70083ed9fca40ac22d79 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 188 | 128 | 7 | a0815eaf68eedd6e5ec4af520df80a6ab4eb0864 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-06 | 191 | 128 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 1.41e-06 | 192 | 128 | 7 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | facs-Pancreas-Exocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 193 | 128 | 7 | c3161a14a40323a58aa202c8a1d6ea0e9c2b9814 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 196 | 128 | 7 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 1.62e-06 | 196 | 128 | 7 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.62e-06 | 196 | 128 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 196 | 128 | 7 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 1.68e-06 | 197 | 128 | 7 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.68e-06 | 197 | 128 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-06 | 198 | 128 | 7 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.73e-06 | 198 | 128 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.79e-06 | 199 | 128 | 7 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.79e-06 | 199 | 128 | 7 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 1.79e-06 | 199 | 128 | 7 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-06 | 199 | 128 | 7 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-06 | 199 | 128 | 7 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.85e-06 | 200 | 128 | 7 | ab4fda0cc95cb8f80ea9f28745013f3248def820 | |
| ToppCell | Tracheal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-06 | 200 | 128 | 7 | efd461c687155c84ef590352207e6fe4ba392a90 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.85e-06 | 200 | 128 | 7 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.85e-06 | 200 | 128 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.96e-06 | 145 | 128 | 6 | 9b69bfdbf91ef197b4c483617aa67498d9d2cd79 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.96e-06 | 145 | 128 | 6 | 31af9fce1dcd7e8ae1604476598e099232017ee9 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.96e-06 | 145 | 128 | 6 | 76f0cde9acdc3ad5948c007dccf312665972c9e6 | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 171 | 128 | 6 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-05 | 171 | 128 | 6 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-05 | 172 | 128 | 6 | bb542f6ca4eb8167129bc84ca1160a54fbb68731 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-05 | 172 | 128 | 6 | aff37b9689b0d30ee7097d997d9588efc475c8fd | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.24e-05 | 177 | 128 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-05 | 177 | 128 | 6 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 178 | 128 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.32e-05 | 179 | 128 | 6 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | facs-SCAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 180 | 128 | 6 | 6c70b6b7480507fa94625013222ad338ee7dd1d9 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 180 | 128 | 6 | 551b8de8d933d11bcd3897aeb2fd033355f958e2 | |
| ToppCell | facs-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 182 | 128 | 6 | 45faefd7cbeac84d2c58650530b902af6ce921f8 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 1.45e-05 | 182 | 128 | 6 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-05 | 183 | 128 | 6 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 184 | 128 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 184 | 128 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 184 | 128 | 6 | 10706441e7695212f95689414f31e8082b5eaf0a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 184 | 128 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 184 | 128 | 6 | 4bb0976a75126ad2b3deb5d2229f0716fafe200e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.59e-05 | 185 | 128 | 6 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-05 | 187 | 128 | 6 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-05 | 190 | 128 | 6 | 4cce4ddb79b7751d0103e10f71156977e0c34439 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 190 | 128 | 6 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.91e-05 | 191 | 128 | 6 | 2b10a73c5d80e83d67a7121fb004a1aa86a537ef | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-05 | 191 | 128 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.91e-05 | 191 | 128 | 6 | 02e1ae144da7274171e055356d10e8d175c5347f | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.91e-05 | 191 | 128 | 6 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | background-Cholangiocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.91e-05 | 191 | 128 | 6 | 99aa8d685767a72bef9f05e7cc8913126a048c39 | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM3|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.91e-05 | 191 | 128 | 6 | 05867b96199a46a415848409130697c810d18937 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.91e-05 | 191 | 128 | 6 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 192 | 128 | 6 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.97e-05 | 192 | 128 | 6 | 34505a13b8a47c9286c560122fa7861b9c331a08 | |
| ToppCell | COVID-19-Myeloid-TRAM1|COVID-19 / Condition, Lineage and Cell class | 1.97e-05 | 192 | 128 | 6 | 52b8578699325b0d35a2d3ba36772096130ccc0c | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.97e-05 | 192 | 128 | 6 | 57c1410ebf90c230993e065eb78385daa3360960 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.97e-05 | 192 | 128 | 6 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 192 | 128 | 6 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.97e-05 | 192 | 128 | 6 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 193 | 128 | 6 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.03e-05 | 193 | 128 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.03e-05 | 193 | 128 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 193 | 128 | 6 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-05 | 193 | 128 | 6 | 50c2832de75b6469f649355c6b9a75e910d32db3 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-05 | 193 | 128 | 6 | 222829c30ebe47f0ed1e035897e3cd4be10b2a11 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 193 | 128 | 6 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 193 | 128 | 6 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.09e-05 | 194 | 128 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.09e-05 | 194 | 128 | 6 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.15e-05 | 195 | 128 | 6 | 2af46e87947c16a7c2c367637e606cfbb8a78528 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-05 | 196 | 128 | 6 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-05 | 196 | 128 | 6 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-05 | 196 | 128 | 6 | 85507488f83d8f71b3ee2ad5e5aa0b6ad6193873 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.27e-05 | 197 | 128 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-05 | 197 | 128 | 6 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-05 | 197 | 128 | 6 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | (5)_Fibroblast-I|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.27e-05 | 197 | 128 | 6 | eb486995ad72a0fbb6410c54e8dcf4ee780c0986 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-05 | 198 | 128 | 6 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-05 | 198 | 128 | 6 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.41e-05 | 199 | 128 | 6 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.41e-05 | 199 | 128 | 6 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.41e-05 | 199 | 128 | 6 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.41e-05 | 199 | 128 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.41e-05 | 199 | 128 | 6 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.41e-05 | 199 | 128 | 6 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-05 | 199 | 128 | 6 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-05 | 199 | 128 | 6 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.47e-05 | 200 | 128 | 6 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.47e-05 | 200 | 128 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.47e-05 | 200 | 128 | 6 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| Drug | mM U | 1.48e-06 | 100 | 127 | 7 | CID000095700 | |
| Disease | basal cell carcinoma | 1.42e-05 | 189 | 122 | 7 | EFO_0004193 | |
| Disease | laminin subunit gamma-2 measurement | 1.70e-05 | 2 | 122 | 2 | EFO_0801756 | |
| Disease | amyloidosis (is_implicated_in) | 1.01e-04 | 4 | 122 | 2 | DOID:9120 (is_implicated_in) | |
| Disease | arginine measurement | 1.15e-04 | 23 | 122 | 3 | EFO_0020990 | |
| Disease | Malignant neoplasm of breast | PNLIPRP1 PDCD6 NUP98 APCS AR BMP1 TGM2 MFGE8 BRCA2 BEND7 TENM1 USP54 GKN1 ZNF281 | 1.46e-04 | 1074 | 122 | 14 | C0006142 |
| Disease | Inflammatory Myofibroblastic Tumor | 2.52e-04 | 6 | 122 | 2 | C0334121 | |
| Disease | Lymphopenia | 3.51e-04 | 7 | 122 | 2 | C0024312 | |
| Disease | memory impairment | 4.67e-04 | 8 | 122 | 2 | EFO_0001072 | |
| Disease | lysosomal Pro-X carboxypeptidase measurement | 4.67e-04 | 8 | 122 | 2 | EFO_0801777 | |
| Disease | N-acetylneuraminate measurement | 4.67e-04 | 8 | 122 | 2 | EFO_0020022 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 5.57e-04 | 447 | 122 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Malignant tumor of prostate | 5.99e-04 | 9 | 122 | 2 | cv:C0376358 | |
| Disease | Neurodevelopmental Disorders | 6.11e-04 | 93 | 122 | 4 | C1535926 | |
| Disease | cortical thickness | OMA1 LAMC1 TVP23B ADGRV1 TENM2 ITIH5 SACM1L TG PKHD1 PAM GRIFIN MAEL CPVL | 7.17e-04 | 1113 | 122 | 13 | EFO_0004840 |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 1.28e-03 | 13 | 122 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | cortical surface area measurement | OMA1 ANK3 MYO9B LAMC1 ADGRV1 TENM2 ITIH5 SACM1L TG PKHD1 PAM MAEL MED23 CPVL | 1.35e-03 | 1345 | 122 | 14 | EFO_0010736 |
| Disease | hair color | 1.90e-03 | 311 | 122 | 6 | EFO_0003924 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 1.96e-03 | 16 | 122 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.00e-03 | 128 | 122 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.00e-03 | 128 | 122 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.00e-03 | 128 | 122 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.00e-03 | 128 | 122 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.00e-03 | 128 | 122 | 4 | C0007134 | |
| Disease | brain measurement, neuroimaging measurement | 2.09e-03 | 550 | 122 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | Hypertriglyceridemia | 2.77e-03 | 19 | 122 | 2 | EFO_0004211 | |
| Disease | Prostate cancer, familial | 2.96e-03 | 69 | 122 | 3 | C2931456 | |
| Disease | Adenocarcinoma of prostate | 3.07e-03 | 20 | 122 | 2 | C0007112 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.38e-03 | 148 | 122 | 4 | C0279702 | |
| Disease | lung cancer | 3.38e-03 | 21 | 122 | 2 | MONDO_0008903 | |
| Disease | Bipolar Disorder | 3.76e-03 | 477 | 122 | 7 | C0005586 | |
| Disease | coronary artery disease | OMA1 FAT4 MYO9B LAMC1 CHKB BMP1 GUK1 STOML1 PKHD1 GRIFIN RP1 CHST3 | 3.97e-03 | 1194 | 122 | 12 | EFO_0001645 |
| Disease | Carcinoma of lung | 4.05e-03 | 23 | 122 | 2 | C0684249 | |
| Disease | unipolar depression, bipolar disorder | 4.07e-03 | 156 | 122 | 4 | EFO_0003761, MONDO_0004985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TAGNSNTRFGIAAKY | 211 | P21796 | |
| TAGSNNTRFGIAAKY | 211 | Q9Y277 | |
| YLFNTTFGLLQTNGA | 281 | P59826 | |
| SSAVLGFQSNQIYGF | 591 | Q8NDM7 | |
| KNFFRVSFKNGSQSQ | 411 | Q9NR81 | |
| TGRGFNITYTTFGQN | 681 | Q96PZ7 | |
| FYNNSVIIFSSDNGG | 286 | Q5FYB1 | |
| GGNTNKYSTFSGFII | 221 | Q86Z23 | |
| EGSNGQVFYFIKSQS | 2901 | Q6V0I7 | |
| SGYLEFRQGETNKSF | 1511 | Q8WXG9 | |
| GGNSNKYSTFSGFII | 241 | O75973 | |
| LNLGNFFASRKGYSR | 921 | P19021 | |
| ANNTFYGLSAGVFTK | 421 | P00352 | |
| TKFGSQLNTYTNFFN | 651 | Q008S8 | |
| SRFQFYFQQKGQLTS | 376 | Q9Y259 | |
| SGSRNAQSLGFKINF | 846 | O60879 | |
| FYSDNSVQRKGFQAS | 841 | P13497 | |
| FYGNKTSTQFLNFTP | 741 | O94973 | |
| SSAFLFGATGKYGNQ | 496 | Q16853 | |
| RNTFNFGSKNVSGIS | 1096 | P49792 | |
| SGRSKQFYNQTYGSR | 1036 | Q01804 | |
| IGNSSVGKTSFLFRY | 36 | Q96E17 | |
| SRQGSIKGLVYSSNF | 16 | Q96P11 | |
| TNSGFAYGQNKTAFG | 246 | P52948 | |
| YQKLRVGSSGFSHFN | 346 | Q96JY0 | |
| SIFNTLKRYFQAGGS | 61 | Q8IXH7 | |
| EAFFQGKSLYINSGN | 576 | Q9NPP4 | |
| NGYFTAKARNSFISS | 61 | Q14703 | |
| VQATKTLFPNYFNGS | 496 | Q86UX2 | |
| GARNFGSVQFVASYK | 306 | Q08431 | |
| NLYVAKLNNGFNSGS | 756 | Q4FZB7 | |
| GFLTVNKTYNSNLFF | 76 | Q9H3G5 | |
| KQALSGFGYRLSDQF | 116 | O75340 | |
| ALFGNKGNTHQYSIF | 376 | P54315 | |
| VYEFSTSAGGQQLNK | 831 | Q9ULK4 | |
| FNATVFAYGQTGSGK | 86 | Q2M1P5 | |
| AFGNAKTVYNNNSSR | 206 | Q9HD67 | |
| GFNTVKTFNQRYLVA | 61 | P42785 | |
| DTYNGIFTTLNFQGN | 551 | Q96QE4 | |
| QGARQKFSSLYISQF | 2106 | P00451 | |
| FGIQDFLYSGQKNDS | 136 | Q9H0R1 | |
| SKTYRGAFQNLFQSV | 16 | P10275 | |
| FYRTGQIFSLNSKSG | 281 | Q9Y5G0 | |
| SNGYQRQLSFKNSDG | 996 | Q6IE36 | |
| GNAFTIRTANGGYKF | 366 | D6RGH6 | |
| SFTRAFGKNLQGQTS | 491 | O43422 | |
| LTYLGQKLGGQSFFS | 71 | Q96MD2 | |
| YLVRKQFSSASSQQG | 231 | Q9NR50 | |
| YGNGFAATRLFQKKT | 66 | Q9NS71 | |
| FSGNLYGTSKVAVQA | 76 | Q16774 | |
| YSDFFQGQRTKITIG | 216 | O95352 | |
| SQKGFSYNVVNSSAF | 2041 | P51587 | |
| GNFGQTYDSLNQSIR | 311 | Q5T197 | |
| GIQTIGKYQSANSFT | 371 | Q9H336 | |
| GGNQFFEYTSNKEIR | 481 | Q8N4A0 | |
| LNFVGQYFTHSKGAR | 711 | A8TX70 | |
| SFSKNFGLYNERVGN | 256 | P17174 | |
| LTKGGQQLVFNFYSF | 1376 | Q12955 | |
| AFKRSNAGNLGSYAT | 526 | P20794 | |
| TNGATAVFNTGIFQY | 306 | Q9NR56 | |
| FSNLTGQLDYQGFEK | 426 | P40939 | |
| LGKQVLSYGQNLSFS | 566 | P11047 | |
| KFLGNQQVSYGQSLS | 256 | Q13753 | |
| QFSGQYGTRSRTFQS | 126 | Q8N7W2 | |
| FQGYSSKGLIQRSVF | 426 | Q53GD3 | |
| YFVGQKRTGFSSSQA | 396 | Q6PII3 | |
| GIRTTGSTQSNFNFY | 326 | Q8N8Z6 | |
| GSTQSNFNFYVKSFV | 331 | Q8N8Z6 | |
| FSSATVVGNAFQYGR | 51 | A4D1Z8 | |
| NQSKFFRVLNGYSLQ | 881 | Q14839 | |
| YNGSKASFVQTRGSI | 246 | Q9NTJ5 | |
| SANSVYGFTGAQVGK | 696 | P28340 | |
| FNSVSYRNYGQAKLG | 91 | Q5J8X5 | |
| RAYFNGQSFIASIQK | 1236 | Q16363 | |
| GIKNFKTYGNTNDRF | 591 | P56715 | |
| AYNFLSGQKGISFLG | 81 | Q8N349 | |
| FYFSVEDNGGNKLTN | 1751 | P0C091 | |
| VGRNGSGKSNFFYAI | 31 | Q9UQE7 | |
| YNRISGALFTNDKFQ | 506 | A6NHR9 | |
| KAGVISAQNIYSFGF | 196 | Q8IWB6 | |
| FSFGYFSKQGPTQKQ | 316 | Q8NBX0 | |
| FANKSGQSVLYNALF | 376 | P0DJD1 | |
| SKYLSFFILGQTVQG | 226 | Q86UG4 | |
| QVYSSKTNFTNLLGG | 121 | Q8N5S1 | |
| FSGSVRNNIAYGLQS | 556 | Q03519 | |
| SGRTEQFGKFSVINY | 2071 | Q9UKZ4 | |
| SGLAAVNVSYFFNGR | 1886 | Q9NT68 | |
| YIGSQNVSFSVFNKG | 221 | P08F94 | |
| GVRGQFQTFNASYDT | 1666 | P14410 | |
| GGTFYFNTSRLKQKN | 96 | Q9UQ90 | |
| IEGGNFTTAYFKQQT | 2191 | Q6ZRS2 | |
| FFIRQNKTNSILFYG | 371 | P29508 | |
| GNFHFYSTFNNKRTG | 66 | Q96E52 | |
| RKFNALFAQGNYSEA | 366 | Q00610 | |
| GSGIYSTQKNSSEQF | 411 | Q7LGC8 | |
| FNKSNDGFTTTRSYG | 31 | Q9NY25 | |
| NLSRGFTTNYKTKQG | 336 | Q96SZ6 | |
| FTTNYKTKQGGLRFA | 341 | Q96SZ6 | |
| LTQQGFIYQGSAKFI | 161 | P21980 | |
| SNKFGFGYQLSSRRV | 471 | Q9H4B4 | |
| FQGSQGRAYLFNSVV | 41 | O60688 | |
| QLSSQDVGQASFKYF | 351 | Q9BU70 | |
| GFYINTGTLQFRQAS | 236 | Q6ZU65 | |
| SFGYNLQAQGKFQKA | 286 | Q86TZ1 | |
| QDSYGGKFDRSQSFV | 156 | P02743 | |
| DRFQQSSFGFLGSQK | 16 | Q9UBI4 | |
| NATVFAYGQTGAGKT | 81 | Q7Z4S6 | |
| GQFIYNKTGTTVQTF | 301 | Q8TAQ9 | |
| RFTSQGSYGVAGNVF | 521 | O15344 | |
| RSSSNILGKGFFAAY | 446 | Q9Y6L7 | |
| FAQAFGSQFKSGSRV | 831 | Q9Y2X9 | |
| SNSVAYKNFTNLFGQ | 436 | Q8N9R8 | |
| INFNESYLENGTKGF | 286 | Q9UQD0 | |
| FFIRQNKTNSILFYG | 371 | P48594 | |
| FQGSQGRAYLFNSVV | 41 | Q96QA6 | |
| SKSFQGSHGRAYLFN | 46 | Q96NS1 | |
| DYGNNFLNSSLFTQK | 191 | Q7L2R6 | |
| YGSKYTQNNFITGVR | 121 | Q6PML9 | |
| LGFGGVIAFSSYNKQ | 311 | Q9H1V8 | |
| ATSYFGKQFLRQNTG | 186 | Q9NYZ1 | |
| YASLNFGSKTQQTFG | 781 | Q9Y4F4 | |
| GRTSSKTAFYQALQN | 2531 | P01266 | |
| GKGFSQSSYFQAHQR | 521 | Q14590 | |
| QINCTYQTSGFNGLF | 36 | A0A0B4J238 | |
| FGANKSQYSLTRAQQ | 386 | Q7Z7E8 | |
| KAFGSGYQLSVHQRF | 606 | Q8N7M2 | |
| TSQGAKYTGRTLNYQ | 1516 | Q70EL1 | |
| FQGSQGRAYLFNSVV | 41 | P61236 | |
| RTDQFNGYSKVFGNN | 1691 | Q9NR99 | |
| NNSSRFGKFIQVSYL | 291 | Q13459 |